BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 33169568)

  • 1. [Recent progress in developing of thrombolytic agents for ischemic stroke].
    Xu Y; Chen S; Chen D; Peng S; Cheng Y; Li J; Li Y; Jiang L; Yuan C; Huang M
    Sheng Wu Gong Cheng Xue Bao; 2020 Oct; 36(10):2029-2039. PubMed ID: 33169568
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tissue plasminogen activator-based nanothrombolysis for ischemic stroke.
    Liu S; Feng X; Jin R; Li G
    Expert Opin Drug Deliv; 2018 Feb; 15(2):173-184. PubMed ID: 28944694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tissue Plasminogen Activator-Porous Magnetic Microrods for Targeted Thrombolytic Therapy after Ischemic Stroke.
    Hu J; Huang S; Zhu L; Huang W; Zhao Y; Jin K; ZhuGe Q
    ACS Appl Mater Interfaces; 2018 Oct; 10(39):32988-32997. PubMed ID: 30192506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent advances in targeted delivery of tissue plasminogen activator for enhanced thrombolysis in ischaemic stroke.
    Zamanlu M; Farhoudi M; Eskandani M; Mahmoudi J; Barar J; Rafi M; Omidi Y
    J Drug Target; 2018 Feb; 26(2):95-109. PubMed ID: 28796540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Thrombolytic therapy in acute ischemic stroke: present and future].
    Mori E
    No Shinkei Geka; 2003 Mar; 31(3):249-60. PubMed ID: 12684978
    [No Abstract]   [Full Text] [Related]  

  • 6. Plasminogen activation and thrombolysis for ischemic stroke.
    Medcalf RL; Davis SM
    Int J Stroke; 2012 Jul; 7(5):419-25. PubMed ID: 22463085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tissue-type plasminogen activator in the ischemic brain: more than a thrombolytic.
    Yepes M; Roussel BD; Ali C; Vivien D
    Trends Neurosci; 2009 Jan; 32(1):48-55. PubMed ID: 18963068
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progress in Intravenous Thrombolytic Therapy for Acute Stroke.
    Marshall RS
    JAMA Neurol; 2015 Aug; 72(8):928-34. PubMed ID: 26030910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current status of intravenous thrombolysis for acute ischemic stroke in Asia.
    Sharma VK; Ng KW; Venketasubramanian N; Saqqur M; Teoh HL; Kaul S; Srivastava PM; Sergentanis T; Suwanwela N; Nguyen TH; Lawrence Wong KS; Chan BP
    Int J Stroke; 2011 Dec; 6(6):523-30. PubMed ID: 22111797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Doubts, fears and misconceptions. What is the future of thrombolysis in acute stroke?
    Barber PA; Hill MD; Demchuk AM; Buchan AM
    Can J Neurol Sci; 2000 Nov; 27(4):283-7. PubMed ID: 11097516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Thrombolytic therapy with tPA for the treatment of acute stroke. The Standard Treatment with Alteplase to Reverse Stroke study].
    Di Pasquale G
    Ital Heart J Suppl; 2000 Jul; 1(7):947-8. PubMed ID: 10935744
    [No Abstract]   [Full Text] [Related]  

  • 12. Targeted nano-delivery strategies for facilitating thrombolysis treatment in ischemic stroke.
    Ma H; Jiang Z; Xu J; Liu J; Guo ZN
    Drug Deliv; 2021 Dec; 28(1):357-371. PubMed ID: 33517820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thrombolysis for acute ischaemic stroke.
    Wardlaw JM; Zoppo G; Yamaguchi T; Berge E
    Cochrane Database Syst Rev; 2003; (3):CD000213. PubMed ID: 12917889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tissue plasminogen activator (tPA) for acute ischaemic stroke: why so much has been made of so little.
    Hoffman JR
    Med J Aust; 2003 Oct; 179(7):333-4. PubMed ID: 14503891
    [No Abstract]   [Full Text] [Related]  

  • 15. Tissue plasminogen activator (tPA) for ischemic stroke in patients aged ≥80 years.
    Zhou C; Zhu L; Wu J; Fang S
    Acta Neurol Scand; 2013 Sep; 128(3):e17-8. PubMed ID: 23947769
    [No Abstract]   [Full Text] [Related]  

  • 16. Thromboelastography in patients with acute ischemic stroke.
    Elliott A; Wetzel J; Roper T; Pivalizza E; McCarthy J; Wallace C; Hess MJ; Peng H; Rahbar MH; Sangha N; Grotta JC
    Int J Stroke; 2015 Feb; 10(2):194-201. PubMed ID: 23017088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Appropriate Treatment of Ischemic Stroke That Is Essential for the Reduction of Mortality and Morbidity: Should We Use Hyperbaric Oxygen Therapy Together With Recombinant Tissue Plasminogen Activator for Improving Brain Oxygenation and Before Recombinant Tissue Plasminogen Activator to Minimize the Risk of Massive Bleeding?
    Honore PM; Redant S; Kaefer K; Barreto Gutierrez L; Kugener L; Attou R; Gallerani A; De Bels D
    Crit Care Med; 2021 Aug; 49(8):e806-e807. PubMed ID: 34261938
    [No Abstract]   [Full Text] [Related]  

  • 18.
    Milne WK; Lang E; Ting DK; Atkinson P
    CJEM; 2020 Mar; 22(2):142-148. PubMed ID: 32209153
    [No Abstract]   [Full Text] [Related]  

  • 19. Frequency of thrombolytic therapy in patients with acute ischemic stroke and the risk of in-hospital mortality: the German Stroke Registers Study Group.
    Heuschmann PU; Berger K; Misselwitz B; Hermanek P; Leffmann C; Adelmann M; Buecker-Nott HJ; Rother J; Neundoerfer B; Kolominsky-Rabas PL; ;
    Stroke; 2003 May; 34(5):1106-13. PubMed ID: 12663875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thrombolysis of acute ischemic stroke in a HIV-positive patient: Report and review of literature.
    Sanariya K; Garg A; Das B; Bansal AR
    Neurol India; 2019; 67(2):580-582. PubMed ID: 31085885
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.